Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof
US9295673B2 · kind B2 · utility
4Cited by
157References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2012 |
| Grant date | Mar 29, 2016 |
| Priority date | — |
| Expiry date | Feb 23, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In another aspect, the invention provides for a method for treating a disease condition associated with PI3-kinase α and/or mTOR in a subject. In yet another aspect, a method of inhibiting phosphorylation of both Akt (S473) and Akt (T308) in a cell is set forth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.